Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CytomX Therapeutics (CTMX) Times Interest Earned (2016 - 2017)

CytomX Therapeutics' Times Interest Earned history spans 4 years, with the latest figure at -$41.82 for Q1 2017.

  • For Q1 2017, Times Interest Earned rose 8.78% year-over-year to -$41.82; the TTM value through Dec 2017 reached -$224.56, down 536.52%, while the annual FY2016 figure was -$35.28, 84.03% down from the prior year.
  • Times Interest Earned reached -$41.82 in Q1 2017 per CTMX's latest filing, down from -$36.58 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$13.58 in Q2 2015 to a low of -$45.84 in Q1 2016.
  • Average Times Interest Earned over 4 years is -$30.84, with a median of -$30.66 recorded in 2016.
  • Peak YoY movement for Times Interest Earned: skyrocketed 46.99% in 2015, then plummeted 125.74% in 2016.
  • A 4-year view of Times Interest Earned shows it stood at -$42.74 in 2014, then grew by 28.3% to -$30.65 in 2015, then dropped by 19.35% to -$36.58 in 2016, then decreased by 14.31% to -$41.82 in 2017.
  • Per Business Quant, the three most recent readings for CTMX's Times Interest Earned are -$41.82 (Q1 2017), -$36.58 (Q4 2016), and -$30.95 (Q3 2016).